DGIdb - DPP4 Gene Record

DPP4 1803 Druggable Genome

Alternate Names:

1803
DIPEPTIDYL PEPTIDASE 4
DPP4
ADABP
ADCP2
CD26
DPPIV
TP103
102720
3009
ENSG00000197635
OTTHUMG00000132056
Dipeptidyl peptidase IV
Dipeptidyl peptidase 4 membrane form
Dipeptidyl peptidase 4 soluble form
Adenosine deaminase complexing protein 2
T-cell activation antigen CD26
CD_antigen=CD26
Dipeptidyl peptidase IV membrane form
Dipeptidyl peptidase IV soluble form
ADCP-2
DPP IV
P27487
DPP4_HUMAN
DIPEPTIDYL PEPTIDASE 4 (EC 3.4.14.5) (DIPEPTIDYL PEPTIDASE IV) (DPP IV) (T-CELL ACTIVATION ANTIGEN CD26) (TP103) (ADENOSINE DEAMINASE COMPLEXING PROTEIN-2) (ADABP) [CONTAINS: DIPEPTIDYL PEPTIDASE 4 MEMBRANE FORM (DIPEPTIDYL PEPTIDASE IV MEMBRANE FORM); DI
DPP-4
T31391

Gene Info:

Human Readable Name	PROTEASE
Target Subclass	3.4.14.5
Target Main Class	Enzymes
Human Readable Name	DRUGGABLE GENOME
Target Class	Enzymes
Target Subclass	EC:3.4.14.5
Interpro Type	Domain
Interpro Name	Peptidase S9, prolyl oligopeptidase, catalytic domain
Interpro Acc	IPR001375
Interpro Short Name	Peptidase_S9
Uniprot Evidence	1: Evidence at protein level
Uniprot Status	Swiss-Prot
Gene Biotype	PROTEIN_CODING

(8 More Sources)

Gene Categories: Category Details

CELL SURFACE
PROTEASE
DRUGGABLE GENOME

Publications:

Gupta et al., 2009, Emerging drug candidates of dipeptidyl peptidase IV (DPP IV) inhibitor class for the treatment of Type 2 Diabetes., Curr Drug Targets
Ahrén et al., 2004, Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes., Diabetes Care
Mentlein et al., 1993, Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum., Eur. J. Biochem.
Forst et al., 2012, Linagliptin, a dipeptidyl peptidase-4 inhibitor with a unique pharmacological profile, and efficacy in a broad range of patients with type 2 diabetes., Expert Opin Pharmacother
Augeri et al., 2005, Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes., J. Med. Chem.
Wang et al., 2006, Enalapril increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system., J. Mol. Cell. Cardiol.
Berman et al., 2000, The Protein Data Bank., Nucleic Acids Res.
Dai H et al., 2011, The pharmacokinetics of PF-734200, a DPP-IV inhibitor, in subjects with renal insufficiency., Br J Clin Pharmacol
Diez-Torrubia A et al., 2013, Novel water-soluble prodrugs of acyclovir cleavable by the dipeptidyl-peptidase IV (DPP IV/CD26) enzyme., Eur J Med Chem
Bergman et al., 2006, Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers., Clin Ther
Gallwitz, 2007, Sitagliptin: Profile of a novel DPP-4 inhibitor for the treatment of type 2 diabetes., Drugs Today
Pratley et al., 2007, Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes., Curr Med Res Opin
Lyseng-Williamson, 2007, Sitagliptin., Drugs
Chen et al., 2002, TTD: Therapeutic Target Database., Nucleic Acids Res.
Richter et al., 2008, Emerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes., Vasc Health Risk Manag
Herman et al., 2005, Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral doses., Clin. Pharmacol. Ther.
Karasik et al., 2008, Sitagliptin, a DPP-4 inhibitor for the treatment of patients with type 2 diabetes: a review of recent clinical trials., Curr Med Res Opin
Miller et al., Sitagliptin: a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes., Ann Pharmacother
Herman et al., 2006, Pharmacokinetics and pharmacodynamic effects of the oral DPP-4 inhibitor sitagliptin in middle-aged obese subjects., J Clin Pharmacol
Gallwitz, 2006, Therapies for the treatment of type 2 diabetes mellitus based on incretin action., Minerva Endocrinol.
Hermansen et al., 2007, Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin., Diabetes Obes Metab
Byrd et al., 2007, Dipeptidyl peptidase IV deficiency increases susceptibility to angiotensin-converting enzyme inhibitor-induced peritracheal edema., J. Allergy Clin. Immunol.
Bloomgarden ZT, 2009, Diabetes treatment., Diabetes Care

SITAGLIPTIN DPP4

Interaction Score: 12.88

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Trial Name Sitagliptin

Novel drug target Established target

PMIDs:
16490580 17315049 17407649 17352516 11752352 19065993 16338283 18182122 16868220 16855072 16682937 17593236

Sources:
TdgClinicalTrial TEND TTD
GOSOGLIPTIN DPP4

Interaction Score: 10.3

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Dipeptidyl peptidase IV inhibitor

Direct Interaction yes

PMIDs:
10592235 21366665

Sources:
ChemblInteractions TTD
SAXAGLIPTIN DPP4

Interaction Score: 10.3

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Trial Name Saxagliptin

Novel drug target Established target

PMIDs:
16033281

Sources:
TdgClinicalTrial TEND TTD
VILDAGLIPTIN DPP4

Interaction Score: 7.73

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Trial Name vildagliptin, LAF 237,Galvus, Equa

Novel drug target Established target

Mechanism of Interaction Dipeptidyl peptidase IV inhibitor

PMIDs:
19149538 15562200 8100523

Sources:
TdgClinicalTrial ChemblInteractions TTD
DUTOGLIPTIN DPP4

Interaction Score: 5.15

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name dutogliptin, PHX1149

Novel drug target Established target

PMIDs:
None found

Sources:
TdgClinicalTrial TTD
ANAGLIPTIN DPP4

Interaction Score: 5.15

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
19246581

Sources:
TTD
VALACYCLOVIR DPP4

Interaction Score: 5.15

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
24185376

Sources:
DTC
BISEGLIPTIN DPP4

Interaction Score: 5.15

Interaction Types & Directionality:

n/a

Interaction Info:

Novel drug target Established target

Trial Name KRP-104

PMIDs:
None found

Sources:
TdgClinicalTrial TTD
ALOGLIPTIN DPP4

Interaction Score: 5.15

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Novel drug target Established target

Trial Name alogliptin, SYR-322,Nesina

PMIDs:
None found

Sources:
TdgClinicalTrial TTD
BEGELOMAB DPP4

Interaction Score: 5.15

Interaction Types & Directionality:

antibody (inhibitory)

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Dipeptidyl peptidase IV inhibitor

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions TTD
LINAGLIPTIN DPP4

Interaction Score: 3.86

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Dipeptidyl peptidase IV inhibitor

Direct Interaction yes

PMIDs:
22149370

Sources:
ChemblInteractions TTD
ALOGLIPTIN BENZOATE DPP4

Interaction Score: 2.58

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Dipeptidyl peptidase IV inhibitor

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
TENELIGLIPTIN DPP4

Interaction Score: 2.58

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

PMIDs:
None found

Sources:
TTD
TRELAGLIPTIN DPP4

Interaction Score: 2.58

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
TTD
TRELAGLIPTIN SUCCINATE DPP4

Interaction Score: 2.58

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Dipeptidyl peptidase IV inhibitor

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
SAXAGLIPTIN HYDROCHLORIDE DPP4

Interaction Score: 2.58

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Dipeptidyl peptidase IV inhibitor

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
CARMEGLIPTIN DPP4

Interaction Score: 2.58

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Dipeptidyl peptidase IV inhibitor

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
GEMIGLIPTIN DPP4

Interaction Score: 2.58

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
TTD
SITAGLIPTIN PHOSPHATE DPP4

Interaction Score: 2.58

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Dipeptidyl peptidase IV inhibitor

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
EVOGLIPTIN DPP4

Interaction Score: 2.58

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
TTD
DENAGLIPTIN DPP4

Interaction Score: 2.58

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
TTD
OMARIGLIPTIN DPP4

Interaction Score: 2.58

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Dipeptidyl peptidase IV inhibitor

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions TTD
CAPTOPRIL DPP4

Interaction Score: 0.4

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
17531305

Sources:
NCI
ENALAPRIL DPP4

Interaction Score: 0.26

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
16678199

Sources:
NCI

Ensembl: ENSG00000197635
- Version: 101_38
Alternate Names:

DPP4 Ensembl Gene Name

Gene Info:

Gene Biotype PROTEIN_CODING

Publications:

RussLampel: ENSG00000197635

Version: 26-July-2011

Alternate Names:

DIPEPTIDYL PEPTIDASE 4 (EC 3.4.14.5) (DIPEPTIDYL PEPTIDASE IV) (DPP IV) (T-CELL ACTIVATION ANTIGEN CD26) (TP103) (ADENOSINE DEAMINASE COMPLEXING PROTEIN-2) (ADABP) [CONTAINS: DIPEPTIDYL PEPTIDASE 4 MEMBRANE FORM (DIPEPTIDYL PEPTIDASE IV MEMBRANE FORM); DI Description

ENSG00000197635 Ensembl Gene Id

DPP4 Display Id

Gene Info:

Human Readable Name DRUGGABLE GENOME

Gene Categories:

DRUGGABLE GENOME

Publications:

HopkinsGroom: P27487
- Version: 11-September-2012
Alternate Names:

1803 Entrez Gene Id

DPP4 Uniprot Gene Name

P27487 Uniprot Accession

Gene Info:

Human Readable Name DRUGGABLE GENOME

Interpro Type Domain

Interpro Name Peptidase S9, prolyl oligopeptidase, catalytic domain

Gene Categories:

PROTEASE, DRUGGABLE GENOME

Publications:
TEND: P27487
- Version: 01-August-2011
Alternate Names:

DPP4 Gene Symbol

ENSG00000197635 Ensembl Gene Id

1803 Entrez Gene Id

Gene Info:

Target Subclass 3.4.14.5

Target Main Class Enzymes

Publications:
TdgClinicalTrial: P27487
- Version: January-2014
Alternate Names:

DPP4 Gene Symbol

Gene Info:

Target Class Enzymes

Target Subclass EC:3.4.14.5

Publications:

TTD: Dipeptidyl peptidase 4

Version: 2020.06.01

Alternate Names:

DPP-4 TTD Gene Abbreviation

T31391 TTD Target ID

Gene Info:

Publications:

Davidson JA, 2010, Incorporating incretin-based therapies into clinical practice: differences between glucagon-like Peptide 1 receptor agonists and dipeptidyl peptidase 4 inhibitors., Mayo Clin Proc

Bloomgarden ZT, 2009, Diabetes treatment., Diabetes Care

NCI: DPP4

Version: 14-September-2017

Alternate Names:

Gene Info:

Publications:

Halperin et al., 1998, Immunological markers among workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin., Occup Environ Med

Wang et al., 2006, Enalapril increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system., J. Mol. Cell. Cardiol.

Byrd et al., 2007, Dipeptidyl peptidase IV deficiency increases susceptibility to angiotensin-converting enzyme inhibitor-induced peritracheal edema., J. Allergy Clin. Immunol.

DTC: DPP4
- Version: 02-September-2020
Alternate Names:

Gene Info:

Publications:

Diez-Torrubia A et al., 2013, Novel water-soluble prodrugs of acyclovir cleavable by the dipeptidyl-peptidase IV (DPP IV/CD26) enzyme., Eur J Med Chem
HingoraniCasas: ENSG00000197635
- Version: 31-May-2017
Alternate Names:

ENSG00000197635 Gene Symbol

DPP4 Ensembl Id

Gene Info:

Gene Categories:

DRUGGABLE GENOME

Publications:
ChemblInteractions: ADCP2
- Version: chembl_23
Alternate Names:

CD26 GENE_SYMBOL

DPP4 GENE_SYMBOL

Dipeptidyl peptidase 4 UNIPROT

Gene Info:

Publications:
GO: DPP4
- Version: 01-February-2022
Alternate Names:

ADCP2 GO Gene Synonym

CD26 GO Gene Synonym

Gene Info:

Gene Categories:

CELL SURFACE

Publications:
dGene: DPP4
- Version: 27-Jun-2013
Alternate Names:

1803 Gene ID

ADABP dGene Synonym

ADCP2 dGene Synonym

Gene Info:

Gene Categories:

PROTEASE

Publications:

Mechanism of Interaction	Dipeptidyl peptidase IV inhibitor
Direct Interaction	yes

Trial Name	vildagliptin, LAF 237,Galvus, Equa
Novel drug target	Established target
Mechanism of Interaction	Dipeptidyl peptidase IV inhibitor

Trial Name	dutogliptin, PHX1149
Novel drug target	Established target

DIPEPTIDYL PEPTIDASE 4 (EC 3.4.14.5) (DIPEPTIDYL PEPTIDASE IV) (DPP IV) (T-CELL ACTIVATION ANTIGEN CD26) (TP103) (ADENOSINE DEAMINASE COMPLEXING PROTEIN-2) (ADABP) [CONTAINS: DIPEPTIDYL PEPTIDASE 4 MEMBRANE FORM (DIPEPTIDYL PEPTIDASE IV MEMBRANE FORM); DI	Description
ENSG00000197635	Ensembl Gene Id
DPP4	Display Id

1803	Entrez Gene Id
DPP4	Uniprot Gene Name
P27487	Uniprot Accession

DPP4	Gene Symbol
ENSG00000197635	Ensembl Gene Id
1803	Entrez Gene Id

antibody (inhibitory)
inhibitor (inhibitory)

DPP4 Gene Record

DPP4 1803 Druggable Genome

Alternate Names:

Gene Info:

Gene Categories: Category Details

Publications:

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Trial Name Sitagliptin Novel drug target Established target

PMIDs: 16490580 17315049 17407649 17352516 11752352 19065993 16338283 18182122 16868220 16855072 16682937 17593236

Sources: TdgClinicalTrial TEND TTD

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Mechanism of Interaction Dipeptidyl peptidase IV inhibitor Direct Interaction yes

PMIDs: 10592235 21366665

Sources: ChemblInteractions TTD

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Trial Name Saxagliptin Novel drug target Established target

PMIDs: 16033281

Sources: TdgClinicalTrial TEND TTD

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Trial Name vildagliptin, LAF 237,Galvus, Equa Novel drug target Established target Mechanism of Interaction Dipeptidyl peptidase IV inhibitor

PMIDs: 19149538 15562200 8100523

Sources: TdgClinicalTrial ChemblInteractions TTD

Interaction Types & Directionality: n/a

Interaction Info: Trial Name dutogliptin, PHX1149 Novel drug target Established target

PMIDs: None found

Sources: TdgClinicalTrial TTD

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 19246581

Sources: TTD

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 24185376

Sources: DTC

Interaction Types & Directionality: n/a

Interaction Info: Novel drug target Established target Trial Name KRP-104

PMIDs: None found

Sources: TdgClinicalTrial TTD

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Novel drug target Established target Trial Name alogliptin, SYR-322,Nesina

PMIDs: None found

Sources: TdgClinicalTrial TTD

Interaction Types & Directionality: antibody (inhibitory) inhibitor (inhibitory)

Interaction Info: Mechanism of Interaction Dipeptidyl peptidase IV inhibitor Direct Interaction yes

PMIDs: None found

Sources: ChemblInteractions TTD

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Mechanism of Interaction Dipeptidyl peptidase IV inhibitor Direct Interaction yes

PMIDs: 22149370

Sources: ChemblInteractions TTD

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Mechanism of Interaction Dipeptidyl peptidase IV inhibitor Direct Interaction yes

PMIDs: None found

Sources: ChemblInteractions

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info:

PMIDs: None found

Sources: TTD

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: None found

Sources: TTD

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Mechanism of Interaction Dipeptidyl peptidase IV inhibitor Direct Interaction yes

PMIDs: None found

Sources: ChemblInteractions

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Mechanism of Interaction Dipeptidyl peptidase IV inhibitor Direct Interaction yes

PMIDs: None found

Sources: ChemblInteractions

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Mechanism of Interaction Dipeptidyl peptidase IV inhibitor Direct Interaction yes

PMIDs: None found

Sources: ChemblInteractions

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: None found

Sources: TTD

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Mechanism of Interaction Dipeptidyl peptidase IV inhibitor Direct Interaction yes

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Trial Name Sitagliptin

Novel drug target Established target

PMIDs:
16490580 17315049 17407649 17352516 11752352 19065993 16338283 18182122 16868220 16855072 16682937 17593236

Sources:
TdgClinicalTrial TEND TTD

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Dipeptidyl peptidase IV inhibitor

Direct Interaction yes

PMIDs:
10592235 21366665

Sources:
ChemblInteractions TTD

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Trial Name Saxagliptin

Novel drug target Established target

PMIDs:
16033281

Sources:
TdgClinicalTrial TEND TTD

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Trial Name vildagliptin, LAF 237,Galvus, Equa

Novel drug target Established target

Mechanism of Interaction Dipeptidyl peptidase IV inhibitor

PMIDs:
19149538 15562200 8100523

Sources:
TdgClinicalTrial ChemblInteractions TTD

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name dutogliptin, PHX1149

Novel drug target Established target

PMIDs:
None found

Sources:
TdgClinicalTrial TTD

Interaction Types & Directionality:

n/a

PMIDs:
19246581

Sources:
TTD

Interaction Types & Directionality:

n/a

PMIDs:
24185376

Sources:
DTC

Interaction Types & Directionality:

n/a

Interaction Info:

Novel drug target Established target

Trial Name KRP-104

PMIDs:
None found

Sources:
TdgClinicalTrial TTD

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Novel drug target Established target

Trial Name alogliptin, SYR-322,Nesina

PMIDs:
None found

Sources:
TdgClinicalTrial TTD

Interaction Types & Directionality:

antibody (inhibitory)

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Dipeptidyl peptidase IV inhibitor

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions TTD

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Dipeptidyl peptidase IV inhibitor

Direct Interaction yes

PMIDs:
22149370

Sources:
ChemblInteractions TTD

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Dipeptidyl peptidase IV inhibitor

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions

Interaction Types & Directionality:

inhibitor (inhibitory)

PMIDs:
None found

Sources:
TTD

Interaction Types & Directionality:

n/a

PMIDs:
None found

Sources:
TTD

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Dipeptidyl peptidase IV inhibitor

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Dipeptidyl peptidase IV inhibitor

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Dipeptidyl peptidase IV inhibitor

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions

Interaction Types & Directionality:

n/a

PMIDs:
None found

Sources:
TTD

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Dipeptidyl peptidase IV inhibitor

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions

Interaction Types & Directionality:

n/a

PMIDs:
None found

Sources:
TTD

Interaction Types & Directionality:

n/a

PMIDs:
None found

Sources:
TTD

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Dipeptidyl peptidase IV inhibitor

Direct Interaction yes

PMIDs:
None found